Research on the remote treatment of nearsightedness with External Qi by Pangu Shengong

Practicing Pangu Shengong not only heals and strengthens the body, but also sends external qi to others through the mind to help them cure various diseases. There have been many successful cases, but there is a lack of rigorous scientific testing in this area. Therefore, it is important to devise an easier way to certify to test the remote effects and healing power of Pangu Shengong: (1) Methods: Two classes of the same grade with similar number of students were selected in an elementary school . One was the experimental group and the other was the control group. The Qi sender sends Qi to the students in the experimental group regularly from a distance of 25.6 kilometers away from the school by Pangu Shengong.

A Study on Health Recognition of Local Residents to Establish Local Healthcare Projects in the with-COVID-19 Age

Objectives: This study aimed to analyze the awareness of local residents regarding healthcare projects and to suggest some ideas for the revision of local ones. Methods: To delve into the opinions of local residents, the author of this study created a questionnaire composed of eight questions on the general characteristics of the respondents, eight questions on satisfaction with health centers, 16 questions on the awareness of healthcare projects, and 22 questions on local healthcare. The survey was conducted for 409 residents who visited public centers in Gimcheon from 15 March to 14 April 2021. Results: Data analysis revealed the following: The proportion of local residents who use health centers was 39.1%, and those users visit health centers, on average, 3.92 times a year. Among healthcare projects, the project known by the highest proportion of people was vaccinations (84.5%), which was also the project that was most used (38.1%). Among healthcare projects needed in the with-COVID-19 age, respondents awarded the highest score to vaccinations (4.15 points on a five-point Likert scale) and the second highest score to infectious disease management (4.12). Conclusions: For healthcare projects, central and local governments should focus on activating vaccinations, solving the problem of medical accessibility through untact remote treatment and establishing national infectious disease-specializing hospitals and local infectious disease management based on such national hospitals.

Personification of the selection of pharmacological treatment of stress and post-stress disorders based on biometric data

Scientific researches have proven the pathogenetic relationship between stress and the development of a wide range of diseases. The impact of stress to the development of somatic diseases is well known, but greatly underestimated, since the treatment of stress and the correction of its consequences is an important aspect in the prevention and treatment of any, even infectious diseases, which was proved during the COVID-19 pandemic in 2020. The introduction of individual mobile medicine devices (M-Health) into a wide medical practice makes it possible to provide not only remote monitoring of the patients condition, but also to conduct remote treatment, with the selection and correction of drug therapy based on objective biometric data.

OP0155-HPR REMOTE MANAGEMENT OF RHEUMATOID ARTHRITIS VS ROUTINE OUTPATIENT FOLLOW-UP: A PROSPECTIVE, LONGITUDINAL REAL-WORLD STUDY

Background:Remote management of rheumatoid arthritis (RA) using patient self-assessment of disease and patient-reported outcomes has potential to inform timely clinical decisions on disease management, reduce burden on busy rheumatology services and promote effective self-management. However, it is unclear how patients’ self-reporting relates to treatment decisions.Objectives:To determine the agreement between remote treatment decisions based on patient self-assessment questionnaire assessed blindly by a health professional and treatment decisions based on routine outpatient monitoring appointments.Methods:This was a prospective real-world study including patients (who gave informed consent) enrolled in an observational study of RA patients starting a new biologic therapy.Enrolled patients continued with their usual care and usual clinic monitoring. In addition, they completed at home, self-assessment questionnaires at monthly intervals, including: two self-reported components which are collected as part of routine clinical practice (joint stiffness and flare), visual analogue scales for pain, global health and fatigue; and HAQ-DI and self-efficacy scales (Arthritis Self-Efficacy Pain and Other Symptoms subscales) at inclusion visits, 12 and 24 months.Remote treatment decisions were made by an independent (blinded) health professional, based on the self-assessment questionnaires and information collected in the study: medical history, ongoing therapies for RA, clinical outcomes, adverse events and toxicity. In this analysis, the independent blinded clinician did not have the same information as the routine hospital visit clinician (blood results and joints assessment).The remote decisions were matched with the hospital visit decisions (within 2 weeks) and the measure of agreement between the 2 raters (independent blinded health professional and clinician at outpatient appointment) were evaluated using kappa coefficient: <0.2, 0.21-0.40, 0.41-0.60, 0.61-0.80 and 0.81-0.99 representing poor, fair, moderate, substantial and almost perfect agreement respectively.Results:A total of 72 RA patients were recruited into the sub-study: mean (SD) age 57.8 (11.6), disease duration 11.7 (10.3) and 52 (87%) were female. The pre-categorised remote decisions were: no change to biologic, stop biologic, add concomitant DMARD, reduction/removal of a concomitant DMARD and bring in for review. There were 57 matched decisions between the independent health professional and the outpatient clinicians. The outpatient clinician made 7 changes to biologic and 18 non-biologic therapy changes, while the remote health professional made 1 change to biologic and 17 changes to a non-biologic DMARD including bringing in for review. The self-assessment questionnaires reported 34 RA flares of which 21 had resolved. In the matched decisions, there was only one adverse event that needed stopping treatment, identified by both the remote and the outpatient treatment. The independent health professional and the outpatient clinician had a ‘fair’ agreement on changes to biologic therapy (Kappa = 0.226, p = 0.007) and overall changes to RA therapy (Kappa = 0.24, p = 0.07).Conclusion:Remote RA monitoring using patient self-assessment and outcome measures was feasible with fair agreement on treatment decisions. Further work is required on understanding the importance of adding blood test monitoring to remote decision-making.Disclosure of Interests:None declared

How Technology Helps Protect Global Health and Fight the COVID-19 Pandemic

Whether it is mindlessly scrolling through social media, or even using voice assistant devices to order products online, there is no doubt that technology has fundamentally changed our lives. As COVID-19 hospitalizations and deaths climb, new and innovative digital technologies are being harnessed to support the global response to COVID-19 (Whitelaw, Mamas, and Van Spall, 2020). With no effective antiviral treatment in sight and vaccines only just becoming available, global efforts have been focused on containment and prevention strategies. The countries with the most effective handling of the virus have successfully implemented digital technologies to aid in contact tracing, patient diagnosis through artificial intelligence, and telemedicine for remote treatment options.

Patient Attitudes Toward Telepsychiatry During the COVID-19 Pandemic: A Nationwide, Multisite Survey

Background The COVID-19 pandemic and its associated movement restrictions forced a rapid and massive transition to telepsychiatry to successfully maintain care continuity. Objective The aim of this study is to examine a large number of patients’ experiences of, use of, and attitudes toward telepsychiatry. Methods An anonymous 11-question survey was delivered electronically to 14,000 patients receiving telepsychiatry care at 18 participating centers across 11 US states between the months of April and June 2020, including questions about their age and length of service use, as well as experience and satisfaction with telepsychiatry on a 5-point Likert scale. Descriptive statistics were used to analyze and report data. Results In total, 3070 patients with different age ranges participated. The overall experience using telepsychiatry was either excellent or good for 1189 (82.2%) participants using video and 2312 (81.5%) using telephone. In addition, 1922 (63.6%) patients either agreed or strongly agreed that remote treatment sessions (telephone or video) have been just as helpful as in-person treatment. Lack of commute (n=1406, 46.1%) and flexible scheduling/rescheduling (n=1389, 45.5%) were frequently reported advantages of telepsychiatry, whereas missing the clinic/hospital (n=936, 30.7%) and not feeling as connected to their doctor/nurse/therapist (n=752, 24.6%) were the most frequently reported challenges. After the current pandemic resolves, 1937 (64.2%) respondents either agreed or strongly agreed that they would consider using remote treatment sessions in the future. Conclusions Telepsychiatry is very well perceived among a large sample of patients. After the current pandemic resolves, some patients may benefit from continued telepsychiatry, but longitudinal studies are needed to assess impact on clinical outcomes and determine whether patients’ perceptions change over time.